Results are very positive with increase in revenue and profits.The only missing number is the number of clients.JGL expects to have a positive cash flow soon.The shares should be trading in mid 40c. I hold
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025